#United States #New York #Securities #Faruqi & Faruqi #Zynex

Zynex Investors: Urgent Class Action Notification

Zynex, Inc. is currently under scrutiny due to allegations that have surfaced in a federal securities class action lawsuit. The reputable law firm Faruqi & Faruqi, LLP is investigating the claims against the company and is urging affected investors to take action. A key deadline for this class action is rapidly approaching—April 21, 2026. It is crucial for investors who have experienced financial losses to understand their rights and options during this time.

Background of Zynex, Inc.

Founded in 1996, Zynex has evolved into a key player in the medical device industry, particularly in pain management and rehabilitation. The company's primary products include electrical stimulation devices and other therapeutic tools aimed at improving patient outcomes. However, recent events have cast a shadow over its operations and financial integrity.

Allegations Against Zynex

The allegations against Zynex include severe breaches of federal securities laws. Specific claims point towards misleading statements made by the company’s executives and a lack of transparency concerning financial operations. Here’s a summary of the key points from the allegations:

• - Product Overproduction: Zynex is accused of overproducing its medical devices, including electrodes much beyond actual needs, which has artificially inflated revenue figures.
• - Fraudulent Billing Practices: The company reportedly engaged in fraudulent overbilling practices that caught the attention of major insurers, including Tricare, the health insurance program serving U.S. military members.
• - Legal Actions: Legal complications arose when Travelers initiated a lawsuit against Zynex, alleging that their practices led to a fraudulent scheme involving over $23 million in questionable claims.
• - Inadequate Compliance: The company has been criticized for prioritizing aggressive sales strategies over compliance with industry standards and regulations.
• - Dramatic Revenue Decline: Following a release of financial results in early 2025 that revealed significant revenue shortfalls attributed to delayed payments, Zynex's stock plummeted rapidly.

Financial Consequences for Investors

The allegations have resulted in severe repercussions for Zynex’s stock performance. Investors who acquired Zynex securities between February 25, 2021, and December 15, 2025, must be aware of their potential financial recoveries through the class action. On two notable occasions—March 2025 and August 2025—the company reported earnings that led to significant stock price drops:

• - In March 2025, after revealing payment suspensions, Zynex's stock dropped by over 51%, signaling investor concerns about its financial stability.
• - In August 2025, amidst regulatory non-compliance admissions, the stock further declined by 45%, marking a loss of trust and stability for investors.

Next Steps for Affected Investors

Investors who have incurred losses during this period are encouraged to act quickly. Faruqi & Faruqi, LLP is inviting potential lead plaintiffs to step forward to help guide this litigation. While any investor can choose to be an absent class member, those who take an active role may lead the efforts in seeking recovery.

For those wishing to learn more or who possess information on Zynex’s operations—whistleblowers, former employees, and shareholders—Faruqi & Faruqi are eager to hear your insights. You can reach out directly to securities litigation partner Josh Wilson at 877-247-4292 or visit their website for further details.

Conclusion

The forthcoming deadline of April 21, 2026, presents a critical window for Zynex investors to secure their rights. As Zynex navigates this challenging time, stakeholders must remain informed about the implications of the ongoing legal proceedings. This case not only highlights the importance of corporate compliance with securities laws but also serves as a reminder for investors to be vigilant in their investments.

Stay updated as this situation unfolds, and don’t hesitate to seek legal counsel regarding your position. Your financial well-being could hinge on the actions you take today.